| 000 | 01645 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517170840.0 | ||
| 264 | 0 | _c20190705 | |
| 008 | 201907s 0 0 eng d | ||
| 022 | _a1537-453X | ||
| 024 | 7 |
_a10.1097/COC.0000000000000403 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPalavalli Parsons, Lavanya H | |
| 245 | 0 | 0 |
_aHypoalbuminemia is a Predictive Factor for Fistula Formation in Recurrent Cervical Cancer. _h[electronic resource] |
| 260 |
_bAmerican journal of clinical oncology _c10 2018 |
||
| 300 |
_a933-937 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xdrug therapy |
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xadverse effects |
| 650 | 0 | 4 |
_aBevacizumab _xadverse effects |
| 650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFistula _xdiagnosis |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoalbuminemia _xchemically induced |
| 650 | 0 | 4 | _aLymphatic Metastasis |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xdrug therapy |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aSalvage Therapy |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 |
_aUterine Cervical Neoplasms _xdrug therapy |
| 700 | 1 | _aRoane, Brandon | |
| 700 | 1 | _aManders, Dustin B | |
| 700 | 1 | _aRichardson, Debra L | |
| 700 | 1 | _aKehoe, Siobhan M | |
| 700 | 1 | _aCarlson, Matthew | |
| 700 | 1 | _aMiller, David S | |
| 700 | 1 | _aLea, Jayanthi S | |
| 773 | 0 |
_tAmerican journal of clinical oncology _gvol. 41 _gno. 10 _gp. 933-937 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/COC.0000000000000403 _zAvailable from publisher's website |
| 999 |
_c27474614 _d27474614 |
||